All Stories

  1. Identification of a histone family gene signature for predicting the prognosis of cervical cancer patients
  2. (−)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells
  3. Understanding immune phenotypes in human gastric disease tissues by multiplexed immunohistochemistry
  4. Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses
  5. (-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease
  6. An Emergence Framework of Carcinogenesis
  7. The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation
  8. Integrin-Linked Kinase Expression in Myeloid Cells Promotes Inflammatory Signaling during Experimental Colitis
  9. ATF3 Repression of BCL-X L Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types
  10. Auto-phosphorylation Represses Protein Kinase R Activity
  11. A non‐canonical function of Ezh2 preserves immune homeostasis
  12. Activation of cGAS-dependent antiviral responses by DNA intercalating agents
  13. Activating Transcription Factor 3 Expression as a Marker of Response to the Histone Deacetylase Inhibitor Pracinostat
  14. Surgical margins in head and neck squamous cell carcinoma: Effect of heat artifact on immunohistochemistry as a future tool for assessment
  15. Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity
  16. Telomerase Deficiency Causes Alveolar Stem Cell Senescence-associated Low-grade Inflammation in Lungs
  17. The protein activator of protein kinase R, PACT/RAX, negatively regulates protein kinase R during mouse anterior pituitary development
  18. The acetyltransferase HAT1 moderates the NF-κB response by regulating the transcription factor PLZF
  19. BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs
  20. Sequence-dependent off-target inhibition of TLR7/8 sensing by synthetic microRNA inhibitors
  21. Molecular dynamics reveal a novel kinase-substrate interface that regulates protein translation
  22. IL-10 regulates Aicda expression through miR-155
  23. Integrin-linked Kinase Modulates Lipopolysaccharide- and Helicobacter pylori -induced Nuclear Factor κB-activated Tumor Necrosis Factor-α Production via Regulation of p65 Serine 536 Phosphorylation
  24. Protein Kinase R and the Inflammasome
  25. The Role of Ets2 Transcription Factor in the Induction of MicroRNA-155 (miR-155) by Lipopolysaccharide and Its Targeting by Interleukin-10
  26. High-density lipoprotein mediates anti-inflammatory reprogramming of macrophages via the transcriptional regulator ATF3
  27. Inosine Modulation of TLR7/8 Sensing
  28. Activating Transcription Factor 3 Contributes to Toll-Like Receptor-Mediated Macrophage Survival via Repression ofBaxandBak
  29. Allan S.Y. Lau (1952–2013) A Dedicated Interferon and Cytokine Biologist and Infectious Disease Physician
  30. Fine tuning type I interferon responses
  31. The use of miRNA microarrays for the analysis of cancer samples with global miRNA decrease
  32. ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton
  33. Conformational rearrangements of RIG-I receptor on formation of a multiprotein:dsRNA assembly
  34. Regulation of Double-Stranded RNA Dependent Protein Kinase Expression and Attenuation of Protein Synthesis Induced by Bacterial Toll-Like Receptors Agonists in the Absence of Interferon
  35. Human Toll-Like Receptor 8 Can Be Cool Too: Implications for Foreign RNA Sensing
  36. A miR-19 regulon that controls NF- B signaling
  37. Regulation of Actin Dynamics by Protein Kinase R Control of Gelsolin Enforces Basal Innate Immune Defense
  38. The Promyelocytic Leukemia Zinc Finger Protein: Two Decades of Molecular Oncology
  39. HDACi: molecular mechanisms and therapeutic implications in the innate immune system
  40. Dynamiting Viruses with MxA
  41. Making Sense of Viral RNA Sensing
  42. Analysis of microRNA turnover in mammalian cells following Dicer1 ablation
  43. siRNA‐induced immunostimulation through TLR7 promotes antitumoral activity against HPV‐driven tumors in vivo
  44. Different modes of interaction by TIAR and HuR with target RNA and DNA
  45. Interferon-Stimulated Genes and Their Protein Products: What and How?
  46. Differentiating the interferon pathway
  47. Genetic modulation of TLR8 response following bacterial phagocytosis
  48. Tumor Cell Response to Synchrotron Microbeam Radiation Therapy Differs Markedly From Cells in Normal Tissues
  49. Role of PKR and Type I IFNs in Viral Control during Primary and Secondary Infection
  50. X4 and R5 HIV-1 have distinct post-entry requirements for uracil DNA glycosylase during infection of primary cells
  51. Viral apoptosis is induced by IRF-3-mediated activation of Bax
  52. Rational Design of Immunostimulatory siRNAs
  53. Monitoring Innate Immune Recruitment by siRNAs in Mammalian Cells
  54. siRNA delivery not Toll-free
  55. Modified vaccinia virus Ankara can activate NF-κB transcription factors through a double-stranded RNA-activated protein kinase (PKR)-dependent pathway during the early phase of virus replication
  56. ATF3 transcription factor and its emerging roles in immunity and cancer
  57. Promyelocytic Leukemia Zinc Finger Protein Regulates Interferon-Mediated Innate Immunity
  58. Latest advances in innate antiviral defence
  59. An Antiviral Response Directed by PKR Phosphorylation of the RNA Helicase A
  60. Differential Expression in Clear Cell Renal Cell Carcinoma Identified by Gene Expression Profiling
  61. Regulation of CRABP-II expression by MycN in Wilms tumor
  62. The p59 oligoadenylate synthetase-like protein possesses antiviral activity that requires the C-terminal ubiquitin-like domain
  63. The Role of PACT in Mediating Gene Induction, PKR Activation, and Apoptosis in Response to Diverse Stimuli
  64. Protein Kinase R-dependent Regulation of Interleukin-10 in Response to Double-stranded RNA
  65. Interferon-inducible antiviral effectors
  66. Determinants of Cytokine Induction by Small Interfering RNA in Human Peripheral Blood Mononuclear Cells
  67. TLR7 Is Involved in Sequence-Specific Sensing of Single-Stranded RNAs in Human Macrophages
  68. Quercetin Ingestion Does Not Alter Cytokine Changes in Athletes Competing in the Western States Endurance Run
  69. Human Immunodeficiency Virus-1/Surface Glycoprotein 120 Induces Apoptosis through RNA-Activated Protein Kinase Signaling in Neurons
  70. Interferons induce an antiviral state in human pancreatic islet cells
  71. The response of mammalian cells to double-stranded RNA
  72. Negative Regulation of TLR-Signaling Pathways by Activating Transcription Factor-3
  73. Novel interferon- -induced gene expression in peripheral blood cells
  74. Fine‐tuning of the innate immune response by microRNAs
  75. Tissue-Specific and Inducer-Specific Differential Induction of ISG56 and ISG54 in Mice
  76. Reduced expression of autotaxin predicts survival in uveal melanoma
  77. Oligoadenylate Synthetase/Protein Kinase R Pathways and αβ TCR+ T Cells Are Required for Adenovirus Vector: IFN-γ Inhibition of Herpes Simplex Virus-1 in Cornea
  78. Gene Modulatory Effects, Pharmacokinetics, and Clinical Tolerance of Interferon-α1b: A Second Member of the Interferon-α Family
  79. Salicylates Trigger Protein Synthesis Inhibition in a Protein Kinase R-like Endoplasmic Reticulum Kinase-dependent Manner
  80. Type I Interferon Inhibits Antibody Responses Induced by a Chimpanzee Adenovirus Vector
  81. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which are negatively involved in lysophosphatidic acid-induced cell invasion
  82. Cystic Fibrosis and Normal Human Airway Epithelial Cell Response to Influenza A Viral Infection.
  83. Cellular Retinoic Acid-Binding Protein II Is a Direct Transcriptional Target of MycN in Neuroblastoma
  84. Replication of Hepatitis C Virus (HCV) RNA in Mouse Embryonic Fibroblasts: Protein Kinase R (PKR)-Dependent and PKR-Independent Mechanisms for Controlling HCV RNA Replication and Mediating Interferon Activities
  85. Functional Annotation of IFN- α -Stimulated Gene Expression Profiles from Sensitive and Resistant Renal Cell Carcinoma Cell Lines
  86. PKR and RNase L Contribute to Protection against Lethal West Nile Virus Infection by Controlling Early Viral Spread in the Periphery and Replication in Neurons
  87. The lack of RNA-dependent protein kinase enhances susceptibility of mice to genital herpes simplex virus type 2 infection
  88. Dynamic Flexibility of Double-stranded RNA Activated PKR in Solution
  89. A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells
  90. OAS and PKR Are Not Required for the Antiviral Effect of Ad:IFN- γ Against Acute HSV-1 in Primary Trigeminal Ganglia Cultures
  91. Stability of CXCL‐8 and Related AU‐Rich mRNAs in the Context of Hepatitis C Virus Replication In Vitro
  92. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation
  93. Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli
  94. Vascular Endothelial Growth Factor (VEGF) Is Suppressed in WT1-Transfected LNCaP Cells
  95. Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro
  96. ARED 3.0: the large and diverse AU-rich transcriptome
  97. “Endogenous adjuvant” activity of the RNA components of lupus autoantigens Sm/RNP and Ro 60
  98. Activation of the mammalian immune system by siRNAs
  99. A transcriptional signaling pathway in the IFN system mediated by 2′-5′-oligoadenylate activation of RNase L
  100. Targeting Specific Cell Types with Silencing RNA
  101. Down-Regulation of p53 by Double-Stranded RNA Modulates the Antiviral Response
  102. RNA-Dependent Protein Kinase Is Required for Alpha-1 Interferon Transgene-Induced Resistance to Genital Herpes Simplex Virus Type 2
  103. Detection of foreign RNA: Implications for RNAi
  104. RNA interference in biology and disease
  105. Analysis of Genes Induced by Sendai Virus Infection of Mutant Cell Lines Reveals Essential Roles of Interferon Regulatory Factor 3, NF-κB, and Interferon but Not Toll-Like Receptor 3
  106. A Gene Expression Signature for Relapse of Primary Wilms Tumors
  107. Double-stranded RNA-dependent protein kinase (PKR) is downregulated by phorbol ester
  108. Expression of IFITM1 in chronic myeloid leukemia patients
  109. Involvement of the Interferon-Regulated Antiviral Proteins PKR and RNase L in Reovirus-Induced Shutoff of Cellular Translation
  110. Dicing with siRNA
  111. Dichotomy between survival and lytic gene expression in RNase L- and PKR-deficient mice transduced with an adenoviral vector expressing murine IFN-β following ocular HSV-1 infection
  112. AU-rich transient response transcripts in the human genome: expressed sequence tag clustering and gene discovery approach
  113. RNase L and Double-Stranded RNA-Dependent Protein Kinase Exert Complementary Roles in Islet Cell Defense during Coxsackievirus Infection
  114. Patterns of coordinate down-regulation of ARE-containing transcripts following immune cell activation
  115. Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia
  116. RNA interference and double-stranded-RNA-activated pathways
  117. Expressed Gene Clusters Associated with Cellular Sensitivity and Resistance Towards Anti-viral and Anti-proliferative Actions of Interferon
  118. Phospholipid Scramblase 1 Potentiates the Antiviral Activity of Interferon
  119. Biochemical Analyses of Multiple Fractions of PKR Purified from Escherichia coli
  120. PKR-Dependent and -Independent Mechanisms Are Involved in Translational Shutoff during Sindbis Virus Infection
  121. Synergistic Activation of Innate Immunity by Double-Stranded RNA and CpG DNA Promotes Enhanced Antitumor Activity
  122. Protein Kinase R (PKR) Interacts with and Activates Mitogen-activated Protein Kinase Kinase 6 (MKK6) in Response to Double-stranded RNA Stimulation
  123. Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
  124. The Wilms Tumor Suppressor-1 Target Gene Podocalyxin Is Transcriptionally Repressed by p53
  125. Distinctive Roles for 2',5'-Oligoadenylate Synthetases and Double-Stranded RNA-Dependent Protein Kinase R in the In Vivo Antiviral Effect of an Adenoviral Vector Expressing Murine IFN- 
  126. Limited role of N-terminal phosphoserine residues in the activation of transcription by p53
  127. Thrombomodulin RNA Is Destabilized Through Its 3′-Untranslated Element in Cells Exposed to IFN-γ
  128. Novel Growth and Death Related Interferon-Stimulated Genes (ISGs) in Melanoma: Greater Potency of IFN- β Compared with IFN- α 2
  129. Derivation and characterization of a Wilms' tumour cell line, WiT 49
  130. Activation of the interferon system by short-interfering RNAs
  131. The murine double-stranded RNA-dependent protein kinase PKR and the murine 2′,5′-oligoadenylate synthetase-dependent RNase L are required for IFN-β-mediated resistance against herpes simplex virus type 1 in primary trigeminal ganglion culture
  132. Differential expression of E-cadherin and   catenin in primary and metastatic Wilms's tumours
  133. TLR2 and TLR4 agonists stimulate unique repertoires of host resistance genes in murine macrophages: interferon-β-dependent signaling in TLR4-mediated responses
  134. IMMUNOLOGY: A Viral On/Off Switch for Interferon
  135. Impaired Innate Host Defense Causes Susceptibility to Respiratory Virus Infections in Cystic Fibrosis
  136. C114 Is a Novel IL-11-inducible Nuclear Double-stranded RNA-binding Protein That Inhibits Protein Kinase R
  137. Type I Interferon Induction Pathway, but Not Released Interferon, Participates in the Maturation of Dendritic Cells Induced by Negative‐Strand RNA Viruses
  138. Poly(dI{middle dot}dC)-induced Toll-like Receptor 3 (TLR3)-mediated Activation of NFkappa B and MAP Kinase Is through an Interleukin-1 Receptor-associated Kinase (IRAK)-independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR
  139. ISG20, a New Interferon-induced RNase Specific for Single-stranded RNA, Defines an Alternative Antiviral Pathway against RNA Genomic Viruses
  140. RNase L Mediates Transient Control of the Interferon Response through Modulation of the Double-stranded RNA-dependent Protein Kinase PKR
  141. Alphavirus Minus-Strand Synthesis and Persistence in Mouse Embryo Fibroblasts Derived from Mice Lacking RNase L and Protein Kinase R
  142. Heterogeneity in Control of mRNA Stability by AU-rich Elements
  143. p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Signaling of mRNA Stability of AU-Rich Element-Containing Transcripts
  144. ARED 2.0: an update of AU-rich element mRNA database
  145. Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways
  146. Functional Replacement of the Carboxy-Terminal Two-Thirds of the Influenza A Virus NS1 Protein with Short Heterologous Dimerization Domains
  147. Absence of PKR Attenuates the Anti-HSV-1 Activity of an Adenoviral Vector Expressing Murine IFN- β
  148. Differential Effect of Murine Alpha/Beta Interferon Transgenes on Antagonization of Herpes Simplex Virus Type 1 Replication
  149. Blockade of Interferon Induction and Action by the E3L Double-Stranded RNA Binding Proteins of Vaccinia Virus
  150. TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages
  151. Interferon-Regulated Pathways That Control Hepatitis B Virus Replication in Transgenic Mice
  152. Editorial
  153. Signal Integration via PKR
  154. RNA-Dependent Protein Kinase PKR Is Required for Activation of NF- B by IFN-  in a STAT1-Independent Pathway
  155. Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3
  156. The Role of NF-κB in the Regulation of the Expression of Wilms Tumor Suppressor Gene WT1
  157. Expression and localization of HGF and met in Wilms' tumours
  158. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins
  159. Negative Regulation of CD8+ T Cell Function by the IFN-Induced and Double-Stranded RNA-Activated Kinase PKR
  160. Characterization of the Gene Encoding the 100-kDa Form of Human 2′,5′Oligoadenylate Synthetase
  161. A dynamically tuned double-stranded RNA binding mechanism for the activation of antiviral kinase PKR
  162. Characterization of a 500-kb Contig Spanning the Region between c-Ha-Ras and MUC2 on Chromosome 11p15.5
  163. Identification of Connective Tissue Growth Factor as a Target of WT1 Transcriptional Regulation
  164. Identification of Critical Residues Required for Suppressor of Cytokine Signaling-specific Regulation of Interleukin-4 Signaling
  165. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin
  166. The B56α Regulatory Subunit of Protein Phosphatase 2A Is a Target for Regulation by Double-Stranded RNA-Dependent Protein Kinase PKR
  167. Central Role of Double-Stranded RNA-Activated Protein Kinase in Microbial Induction of Nitric Oxide Synthase
  168. Effect of Deficiency of the Double-Stranded RNA-Dependent Protein Kinase, PKR, on Antiviral Resistance in the Presence or Absence of Ribonuclease L: HSV-1 Replication Is Particularly Sensitive to Deficiency of the Major IFN-Mediated Enzymes
  169. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene
  170. NF-κB Activation by Double-Stranded-RNA-Activated Protein Kinase (PKR) Is Mediated through NF-κB-Inducing Kinase and IκB Kinase
  171. Induction of E-Selectin Expression by Double-Stranded RNA and TNF-  Is Attenuated in Murine Aortic Endothelial Cells Derived from Double-Stranded RNA-Activated Kinase (PKR)-Null Mice
  172. Regulation of c-myc expression by IFN-γ through Stat1-dependent and -independent pathways
  173. Activation of p38 Mitogen-Activated Protein Kinase and c-Jun NH2-Terminal Kinase by Double-Stranded RNA and Encephalomyocarditis Virus: Involvement of RNase L, Protein Kinase R, and Alternative Pathways
  174. HIV-I TAT Inhibits PKR Activity by Both RNA-Dependent and RNA-Independent Mechanisms
  175. JNK2 and IKKβ Are Required for Activating the Innate Response to Viral Infection
  176. The antiviral enzymes PKR and RNase L suppress gene expression from viral and non-viral based vectors
  177. PKR; a sentinel kinase for cellular stress
  178. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons
  179. DRBP76, a Double-stranded RNA-binding Nuclear Protein, Is Phosphorylated by the Interferon-induced Protein Kinase, PKR
  180. Interferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
  181. The DNA-binding subunit p140 of replication factor C is upregulated in cycling cells and associates with G 1 phase cell cycle regulatory proteins
  182. Involvement of Double-stranded RNA-activated Protein Kinase in the Synergistic Activation of Nuclear Factor- B by Tumor Necrosis Factor-  and  -Interferon in Preneuronal Cells
  183. Translational control perks up
  184. Cell cycle regulation of the double stranded RNA activated protein kinase, PKR
  185. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays
  186. Protein-tyrosine Phosphatase Shp-1 Is a Negative Regulator of IL-4- and IL-13-dependent Signal Transduction
  187. Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma
  188. Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent
  189. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation
  190. Genomic Features of Human PKR: Alternative Splicing and a Polymorphic CGG Repeat in the 5′-Untranslated Region
  191. Loss of heterozygosity at chromosome 11p15 in Wilms tumors: identification of two independent regions
  192. Review of Recent Developments in the Molecular Characterization of Recombinant Alfa Interferons on the 40th Anniversary of the Discovery of Interferon
  193. p53, bcl-2, and Bax Expression in Renal Cell Carcinoma
  194. HOW CELLS RESPOND TO INTERFERONS
  195. Two distinct tumor suppressor loci within chromosome 11p15 implicated in breast cancer progression and metastasis
  196. Mutations in the Double-stranded RNA-activated Protein Kinase Insert Region That Uncouple Catalysis from eIF2  Binding
  197. Discussion
  198. Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators.
  199. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAK1
  200. Characterization of the Solution Complex between the Interferon-induced, Double-stranded RNA-activated Protein Kinase and HIV-I Trans-activating Region RNA
  201. A double-stranded RNA-activated protein kinase-dependent pathway mediating stress-induced apoptosis
  202. Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappa B
  203. Specific Binding of the ETS-Domain Protein to the Interferon-Stimulated Response Element
  204. Tissue-specific regulation of theWT1 locus
  205. Expression of Intracellular Interferon Constitutively Activates ISGF3 and Confers Resistance to EMC Viral Infection
  206. Testicular cancer in association with developmental renal anomalies and hypospadias
  207. Human PKR Transfected into Murine Cells Stimulates Expression of Genes under Control of the HIV1 or HTLV-I LTR
  208. Analysis of the wilms tumor suppressor geneWT1 in endometrial carcinoma
  209. HIV-1 Tat Directly Interacts with the Interferon-Induced, Double-Stranded RNA-Dependent Kinase, PKR
  210. Roles of Protein-tyrosine Phosphatases in Stat1 -mediated Cell Signaling
  211. The interferon-inducible double-stranded RNA-activated protein kinase self-associates in vitro and in vivo.
  212. In situ expression of the early growth response gene-1 during murine nephrogenesis
  213. The role of the dsRNA-activated kinase, PKR, in signal transduction
  214. Targeting RNA for Degradation with a (2', 5')-Oligoadenylate Antisense Chimera
  215. Response and Resistance to Interferons and Interacting Cytokines
  216. Mutational Analysis of the Double-stranded RNA (dsRNA) Binding Domain of the dsRNA-activated Protein Kinase, PKR
  217. Microsatellite instability at a single locus (D11S988) on chromosome 11p15.5 as a late event in mammary tumorigenesis
  218. HIV-1 TAR RNA Has an Intrinsic Ability to Activate Interferon-Inducible Enzymes
  219. Blockage of NF-kappa B signaling by selective ablation of an mRNA target by 2-5A antisense chimeras
  220. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B.
  221. The Molecular Genetics of Wilms Tumor
  222. Functional differences in the promoters of the interferon-inducible (2'-5')A oligoadenylate synthetase and 6-16 genes in interferon-resistant Daudi cells
  223. PKR: Proposed Nomenclature for the RNA-Dependent Protein Kinase Induced by Interferon
  224. Localization of the Human Interferon-Induced, ds-RNA Activated p68 Kinase Gene (PRKR) to Chromosome 2p21-p22
  225. Deletion ofWT1andWIT1Genes and Loss of Heterozygosity on Chromosome 11p in Wilms Tumors in Japan
  226. Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor.
  227. The Interferon-Induced Double-Stranded RNA-Activated Human p68 Protein Kinase Potently Inhibits Protein Synthesis in Cultured Cells
  228. Molecular characterization of cytogenetic alterations associated with the Beckwith — Wiedemann syndrome (BWS) phenotype refines the localization and suggests the gene for BWS is imprinted
  229. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination
  230. Interferon-α Activates Binding of Nuclear Factors to a Sequence Element in the c- fos Proto-Oncogene 5′-Flanking Region
  231. Transcriptional activation of human (2'-5')oligoadenylate synthetase gene expression by the phorbol ester 12-O-tetradecanoyl-phorbol 13-acetate in type-I-interferon-treated HL-60 and HeLa cells
  232. Basal expression of the gene (TIMP) encoding the murine tissue inhibitor of metalloproteinases is mediated through AP1- and CCAAT-binding factors
  233. Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase.
  234. Multiple Tumor Suppressor Genes in Multistep Carcinogenesis.
  235. The distal region of 11p13 and associated genetic diseases
  236. Transcriptional regulation of interferon-stimulated genes
  237. Signal Transduction and Transcriptional Regulation of Interferon-α–Stimulated Genes
  238. Regulation of Tumor Necrosis Factor Receptor Expression by Acid-Labile Interferon-α from AIDS Sera
  239. Direct pulsed field gel electrophoresis of Wilms' tumors shows that dna deletions in 11 p 13 are rare
  240. Signal transduction by interferon-alpha through arachidonic acid metabolism
  241. The murine 2-5A synthetase locus: three distinct transcripts from two linked genes
  242. Molecular characterization of Beckwith-Wiedemann syndrome (BWS) patients with partial duplication of chromosome 11p excludes the gene MYOD1 from the BWS region
  243. Wilms tumor locus on 11p13 defined by multiple CpG island-associated transcripts
  244. Tissue, developmental, and tumor-specific expression of divergent transcripts in Wilms tumor
  245. Role for the Wilms tumor gene in genital development?
  246. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
  247. Developmental expression of the endogenous TIMP gene and a TIMP-lacZ fusion gene in transgenic mice.
  248. Constitutional and somatic deletions of two different regions of maternal chromosome 11 in Wilms tumor
  249. Definition of the limits of the Wilms tumor locus on human chromosome 11p13
  250. X chromosome inactivation of the human TIMP gene
  251. Constitutive Expression of a 2′,5′-Oligoadenylate Synthetase cDNA Results in Increased Antiviral Activity and Growth Suppression
  252. Interferon and growth factor modulation of nuclear factors binding to 5? upstream elements of the 2-5A synthetase gene
  253. Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.
  254. The interaction of interferon-α and -γ: Regulation of (2–5)A synthetase activity
  255. Interferon and phorbol esters down-regulate slgM expression by independent pathways
  256. Early Immune Response in Healthy and Immunocompromised Subjects with Primary Varicella-Zoster Virus Infection
  257. Interferon-regulated human 2–5A synthetase gene maps to chromosome 12
  258. Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy.
  259. Differential human interferon alpha receptor expression on proliferating and non-proliferating cells
  260. RFLP detected by an X-Uinked cDNA encoding erythroid-potentiating activity/tissue inhibitor of metalloproteinase (EPA/TIMP)
  261. Elevated Levels of Interferon-Induced 2'-5' Oligoadenylate Synthetase in Generalized Persistent Lymphadenopathy and the Acquired Immunodeficiency Syndrome
  262. Production and characterization of a monoclonal antibody to a human interferon-induced double-stranded RNA-binding Mr 68,000 protein kinase.
  263. The effect of interferon on cells deficient in nucleoside transport or lacking thymidine kinase activity
  264. Molecular cloning of cDNAs from androgen-independent mRNA species of DBA/2 mouse sub-maxillary glands
  265. Differential binding of human interferon-α subtypes to receptors on lymphoblastoid cells
  266. Molecular cloning of partial cDNA copies of two distinct mouse IFN-β mRNAs
  267. The 2–5A (pppA2′ p5′ A2′ p5′ A) system in interferon-treated and control cells
  268. Natural occurrence of 2-5A in interferon-treated EMC virus-infected L cells
  269. Activation of a nuclease by pppA2′p5′ A2′p5′ A in intact cells
  270. The respective roles of the protein kinase and pppA2′ p5′ A2′ p5′ A-activated endonuclease in the inhibition of protein synthesis by double stranded RNA in rabbit reticulocyte lysates
  271. Synthesis and Breakdown of pppA2'p5'A2'p5'A and Transient Inhibition of Protein Synthesis in Extracts from Interferon-Treated and Control Cells
  272. Inhibition of protein synthesis by 2′–5′ linked adenine oligonucleotides in intact cells
  273. Inhibition of cell-free protein synthesis by pppA2′ p5′ A2′ p5′ A: a novel oligonucleotide synthesized by interferon-treated L cell extracts
  274. Solid phase radioimmunoassays using labelled antibodies: A conceptual framework for designing assays
  275. Detection of Double-Stranded RNA in Semliki Forest Virus-Infected Cells by an Indirect Solid Phase Radioimmunoassay: an Assay for Interferon
  276. Antiviral response in insects?
  277. Wilms' Tumor as a Model for Cancer Biology